ProteoNic announces collaboration with TNO

29-Feb-2008

ProteoNic announced it has entered into a collaboration with TNO to further commercialize and validate ProteoNic's UNic(tm) Expression technology in mammalian host systems. ProteoNic will provide expertise in construct design and protein expression optimization. TNO will apply this expertise and the UNic(tm) expression technology to manufacture commercial proteins in CHO cell lines.

"The use of the UNic(tm) expression enhancement technology has helped us tremendously to increase the efficiency of our protein production and has resulted in substantial cost reductions." TNO senior investigator Jan Verheijen commented. "One particular advantage was that downstream processing could remain unaltered, enabling a smooth introduction of the optimized process. The UNic(tm) technology combined with TNO's proprietary QuickZyme technology platform will give a boost to the development and manufacturing of novel protease activity assays."

Other news from the department science

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance